A randomized controlled trial of gemcitabine plus cisplatin versus gemcitabine alone in the treatment of metastatic pancreatic cancer

被引：0
|
作者：
Yee Chao
Chen-Yi Wu
Jack P. Wang
Rheun-Chuan Lee
Wei-Ping Lee
Chung-Pin Li
机构：
[1] Taipei Veterans General Hospital,Cancer Center
[2] National Yang-Ming University School of Medicine,Institute of Public Health
[3] National Yang-Ming University,Department of Dermatology, Heping Fuyou Branch
[4] Taipei City Hospital,Division of Gastroenterology, Department of Medicine
[5] Taipei Veterans General Hospital,Department of Internal Medicine, Yangming Branch
[6] Taipei City Hospital,Department of Radiology
[7] Taipei Veterans General Hospital,Department of Medical Research and Education
[8] Taipei Veterans General Hospital,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2013年 / 72卷
关键词：
Cisplatin; Gemcitabine; Pancreatic cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：637 / 642
页数：5
相关论文
共 50 条
  • [1] A randomized controlled trial of gemcitabine plus cisplatin versus gemcitabine alone in the treatment of metastatic pancreatic cancer
    Chao, Yee
    Wu, Chen-Yi
    Wang, Jack P.
    Lee, Rheun-Chuan
    Lee, Wei-Ping
    Li, Chung-Pin
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (03) : 637 - 642
  • [2] A prospective randomized trial of gemcitabine alone or gemcitabine plus cisplatin in the treatment of metastatic pancreatic cancer
    Li, CP
    Chao, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 349S - 349S
  • [3] Gemcitabine plus cisplatin versus gemcitabine alone in the treatment of pancreatic cancer: a meta-analysis
    Guoqing Ouyang
    Zhipeng Liu
    Shengfu Huang
    Qianglong Li
    Li Xiong
    Xiongying Miao
    Yu Wen
    World Journal of Surgical Oncology, 14
  • [4] Gemcitabine plus cisplatin versus gemcitabine alone in the treatment of pancreatic cancer: a meta-analysis
    Ouyang, Guoqing
    Liu, Zhipeng
    Huang, Shengfu
    Li, Qianglong
    Xiong, Li
    Miao, Xiongying
    Wen, Yu
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2016, 14
  • [5] Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer
    Heinemann, Volker
    Quietzsch, Detlef
    Gieseler, Frank
    Gonnermann, Michael
    Schoenekaes, Herbert
    Rost, Andreas
    Neuhaus, Horst
    Haag, Caroline
    Clemens, Michael
    Heinrich, Bernard
    Vehling-Kaiser, Ursula
    Fuchs, Martin
    Fleckenstein, Doris
    Gesierich, Wolfgang
    Uthgenannt, Dirk
    Einsele, Hermann
    Holstege, Axel
    Hinke, Axel
    Schalhorn, Andreas
    Wilkowski, Ralf
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (24) : 3946 - 3952
  • [6] Gemcitabine plus afatinib versus gemcitabine alone in metastatic pancreatic cancer: An explorative randomized AIO phase II trial (ACCEPT)
    Haas, M.
    Waldschmidt, D.
    Stahl, M.
    Reinacher-Schick, A.
    Freiberg-Richter, J.
    Kaiser, F.
    Kanzler, S.
    Frickhofen, N.
    Seufferlein, T.
    Dechow, T.
    Mahlberg, R. J. C.
    Malfertheiner, P.
    Illerhaus, G.
    Kubicka, S.
    Held, S.
    Westphalen, C. B.
    Kruger, S.
    Boeck, S.
    Heinemann, V.
    ANNALS OF ONCOLOGY, 2018, 29 : 243 - 243
  • [7] A Randomized Phase 2 Trial of Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer: Gemcitabine Alone Versus Gemcitabine Combined with Cisplatin
    Daniel H. Palmer
    Deborah D. Stocken
    Helen Hewitt
    Catherine E. Markham
    A. Bassim Hassan
    Philip J. Johnson
    John A. C. Buckels
    Simon R. Bramhall
    Annals of Surgical Oncology, 2007, 14 : 2088 - 2096
  • [8] A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: Gemcitabine alone versus gemcitabine combined with cisplatin
    Palmer, Daniel H.
    Stocken, Deborah D.
    Hewitt, Helen
    Markham, Catherine E.
    Hassan, A. Bassim
    Johnson, Philip J.
    Buckels, John A. C.
    Bramhall, Simon R.
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (07) : 2088 - 2096
  • [9] Randomized controlled trial of gemcitabine in combination with UFT versus gemcitabine alone in patients with advanced pancreatic cancer.
    Ohkawa, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 346S - 346S
  • [10] Gemcitabine alone versus gemcitabine plus cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic adenocarcinoma: A retrospective analysis of multicenter study
    Inal, A.
    Isikdogan, A.
    Kos, T.
    Algin, E.
    Gumus, M.
    Dikilitas, M.
    Elkiran, E. T.
    Helvaci, K.
    Geredeli, C.
    Dane, F.
    Balakan, O.
    Durnali, A. Gok
    Harputluoglu, H.
    Goksel, G.
    Ozdemir, N.
    Buyukberber, S.
    Yildiz, R.
    Kaplan, M. A.
    Ozkan, M.
    Uncu, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345